✦ LIBER ✦

Reboxetine versus venlafaxine in severe depression. A multinational, double-blind randomised trial

✍ Scribed by P. Such

Book ID: 119575298
Publisher: Elsevier Science
Year: 2001
Tongue: English
Weight: 145 KB
Volume: 11
Category: Article
ISSN: 0924-977X
DOI: 10.1016/s0924-977x(01)80194-2

No coin nor oath required. For personal study only.

📜 SIMILAR VOLUMES

Venlafaxine versus nortriptyline in the

Venlafaxine versus nortriptyline in the treatment of elderly depressed inpatients: a randomised, double-blind, controlled trial

✍ Rob M. Kok; Willem A. Nolen; Thea J. Heeren 📂 Article 📅 2007 🏛 John Wiley and Sons 🌐 English ⚖ 125 KB 👁 2 views

## Abstract ## Background The majority of the trials in the elderly are outpatient trials which excluded psychotic patients and patients with common comorbid physical disorders. Consequently information is lacking about the more complex cases of elderly depressed patients, as found in inpatient wa

Reboxetine versus imipramine in the trea

Reboxetine versus imipramine in the treatment of elderly patients with depressive disorders: a double-blind randomised trial

✍ C. Katona; E. Bercoff; E. Chiu; P. Tack; M. Versiani; H. Woelk 📂 Article 📅 1999 🏛 Elsevier Science 🌐 English ⚖ 164 KB

Paroxetine Versus Clomipramine in Adoles

Paroxetine Versus Clomipramine in Adolescents With Severe Major Depression: A Double-Blind, Randomized, Multicenter Trial

✍ BRACONNIER, ALAIN; LE COENT, RÉMI; COHEN, DAVID 📂 Article 📅 2003 🏛 Elsevier Science 🌐 English ⚖ 123 KB

Fluvoxamine versus fluoxetine in major d

Fluvoxamine versus fluoxetine in major depressive episode: a double-blind randomised comparison

✍ Jean Dalery; Adriaan Honig 📂 Article 📅 2003 🏛 John Wiley and Sons 🌐 English ⚖ 77 KB

## Abstract A double‐blind, multinational study was conducted to compare the efficacy and safety of fluvoxamine and fluoxetine in outpatients with major depressive episode; 184 patients were randomised to fluvoxamine (100 mg/day) or fluoxetine (20 mg/day) for 6 weeks. Both drugs were effective and

Sertraline versus fluvoxamine in the tre

Sertraline versus fluvoxamine in the treatment of elderly patients with major depression: A double-blind, randomised trial

✍ D. Rossini; L. Franchini; E. Smeraldi; R. Zanardi 📂 Article 📅 2002 🏛 Elsevier Science 🌐 English ⚖ 132 KB

Efficacy and tolerability of venlafaxine

Efficacy and tolerability of venlafaxine in geriatric outpatients with major depression: a double-blind, randomised 6-month comparative trial with citalopram

✍ Per Allard; Lars Gram; Kristina Timdahl; Kirsten Behnke; Martin Hanson; Jesper S 📂 Article 📅 2004 🏛 John Wiley and Sons 🌐 English ⚖ 85 KB 👁 2 views

## Abstract ## Background The objectives of the study were to compare efficacy and tolerability of venlafaxine ER 75–150 mg/day with that of citalopram 10–20 mg/day in elderly patients with major depression according to DSM‐IV criteria. ## Methods A randomised, double‐blind, parallel group 6‐mon